Ovarian Cancer Linked to High-Risk Progenitor Cells in Fallopian Tube Stroma
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for early-stage ovarian cancer.
Related Articles
HIMSS helped Changemaker Awardee ‘see the future’ of healthcare
Ilir Kullolli from Stanford Medicine Children’s Health says his 20 years of HIMSS membership and his attendance at HIMSS conferences have connected him with visionary…
This tiny, newborn caterpillar buzzes to defend its territory
The 2-millimeter-long bug is among the smallest animals ever observed performing territorial displays
Bridging the human–AI knowledge gap through concept discovery and transfer in AlphaZero | PNAS
AI systems have attained superhuman performance across various domains. If the hidden knowledge encoded in these highly capable systems can be leve…
Fintech Embraces GenAI – the latest insights from Barclays available now – Innovate Finance – The Voice of Global FinTech
Barclays’ latest report ‘Fintech Embraces GenAI’, reveals insights into 500 fintech leaders across the UK and US, uncovering trends, investment shifts,
Agentic AI Optimisation (AAIO): what it is, how it works, why it matters, and how to deal with it
The emergence of Agentic Artificial Intelligence (AAI) systems capable of independently initiating digital interactions necessitates a new optimisation paradigm
NeuralFeels with neural fields: Visuotactile perception for in-hand manipulation
Neural perception with vision and touch yields robust tracking and reconstruction of novel objects for in-hand manipulation.
Bypassing Size Constraints, Scientists Use CD36 Protein to Deliver Bulky PROTACs
A new strategy for delivering bulky PROTACs to cancerous cells successfully utilizes the CD36 protein pathway on cells’ surfaces.
The Body’s Delta Force: Natural Killer Cells Re-Emerge
Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and autoimmunity.
NSF starts to kill grants that violate Trump’s war on diversity efforts
Attracting women and minorities into science and studying misinformation are no longer priorities, agency says
Leidos, University of Pittsburgh spend $10M for AI disease detection
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.